l-carnitine mitochondrial dysfunction caused by fatty acids and acylcarnitines L-carnitine and Acetyl-L Carnitine: A
Description
doi: 10.5468/ogs.20071
These findings provide evidence of the high safety profile of this type of treatment intervention
While significant progress has been made, further research is required to develop therapies that can effectively halt or reverse disease progression, ultimately improving the lives of individuals with DN
One lethal neonatal form (patient 14) presented metabolic acidosis and hypoketotic hypoglycaemia and died soon in the neonatal period
